Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, bluebird bio Inc increased its cash reserves by 73.31%, or 116.15m. Cash Flow from Financing totalled 196.25m or 665.32% of revenues. In addition the company used 235.05m for operations while cash from investing totalled 154.95m.
Cash flow per share | -1.65 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.2733 |
---|---|
Tangible book value per share | 0.1925 |
More ▼
Balance sheet in USDView more
Current ratio | 0.6831 |
---|---|
Quick ratio | 0.5712 |
Total debt/total equity | 3.60 |
---|---|
Total debt/total capital | 0.7827 |
More ▼